Comparison of histologic findings in age-related macular degeneration with RPE flatmount images.
Journal
Molecular vision
ISSN: 1090-0535
Titre abrégé: Mol Vis
Pays: United States
ID NLM: 9605351
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
08
2018
accepted:
05
02
2019
entrez:
2
3
2019
pubmed:
2
3
2019
medline:
15
6
2019
Statut:
epublish
Résumé
To visualize and analyze ex vivo flatmounted human RPE morphology from patients with age-related macular degeneration (AMD), and to compare the morphology with histologic findings. To establish whether the sub-RPE structures identified en face in RPE flatmount preparations are drusen with histopathological registration in serial sections. To detect characteristic patterns found en face in RPE with the same structures in histological cross sections from eyes from cadavers of patients with AMD. Twenty-eight postmortem eyes from 14 patients (16 eyes with AMD and 12 age-matched control eyes) were oriented and microdissected yielding a RPE-choroid preparation. The tissues were flatmounted, stained with Alexa Fluor 635 Phalloidin (AF635-phalloidin) for f-actin and propidium iodide for DNA, and imaged using confocal microscopy. Portions of tissue from macular regions were processed for electron microscopic examination. After confocal imaging, the samples were remounted for histologic processing, embedded in paraffin, and serially sectioned perpendicular to the plane of the RPE-choroid sheet. Scaled two-dimensional (2D) maps of drusen locations found with the histological cross sections were constructed and correlated with the en face confocal microscopic images. Twenty-eight postmortem eyes with a mean time of death to tissue preservation of 23.7 h (range 8.0–51 h) from 14 donors (seven women and seven men) with an average age of 78 years (range 60–93 years) were evaluated. Eight donors had AMD, and six served as controls. Scattered small, hard drusen were present in the periphery of the eyes with AMD and the healthy eyes. The macular region of the eyes with AMD contained small (<63 µm), medium (63.0–124 µm), and large ( Confocal images of flatmounts from eyes with AMD showed RPE patterns overlying various types of drusen and geographic atrophy that correlated with histologic characteristics. We propose RPE repair mechanisms that may result in the patterns that we observed.
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
70-78Subventions
Organisme : NEI NIH HHS
ID : R01 EY028859
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY006360
Pays : United States
Organisme : RRD VA
ID : I21 RX001924
Pays : United States
Organisme : RRD VA
ID : I01 RX002806
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY021592
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028450
Pays : United States
Organisme : NEI NIH HHS
ID : F31 EY028855
Pays : United States
Organisme : NEI NIH HHS
ID : T32 EY007092
Pays : United States
Références
Surv Ophthalmol. 1999 Jul-Aug;44(1):1-29
pubmed: 10466585
Mol Vis. 1999 Nov 03;5:27
pubmed: 10562651
Mol Vis. 1999 Nov 03;5:31
pubmed: 10562655
Mol Vis. 1999 Nov 03;5:32
pubmed: 10562656
Free Radic Biol Med. 2002 Sep 1;33(5):611-9
pubmed: 12208347
Surv Ophthalmol. 2003 May-Jun;48(3):257-93
pubmed: 12745003
Arch Ophthalmol. 2004 Apr;122(4):598-614
pubmed: 15078679
Biochimie. 2004 Nov;86(11):825-31
pubmed: 15589692
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
Biotechniques. 2007 Jan;42(1):71-5
pubmed: 17269487
Ophthalmology. 2010 Jun;117(6):1280-1
pubmed: 20522345
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):E279-87
pubmed: 21690377
Acta Ophthalmol. 2012 Jun;90(4):299-309
pubmed: 22112056
Mol Aspects Med. 2012 Aug;33(4):376-98
pubmed: 22575354
Retina. 2013 Feb;33(2):265-76
pubmed: 23266879
Ophthalmology. 2013 Apr;120(4):821-8
pubmed: 23357621
Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1603-12
pubmed: 23361506
J Cell Mol Med. 2013 Jul;17(7):833-43
pubmed: 23663427
Pharmacol Rep. 2013;65(2):288-304
pubmed: 23744414
Retina. 2013 Oct;33(9):1800-8
pubmed: 23764969
Invest Ophthalmol Vis Sci. 2013 Nov 05;54(12):7274-83
pubmed: 24114543
Ophthalmology. 2014 Feb;121(2):545-51
pubmed: 24183341
Eur J Ophthalmol. 2014 Jul-Aug;24(4):582-92
pubmed: 24338584
Biomed Res Int. 2014;2014:768026
pubmed: 24707498
Curr Eye Res. 2015 Apr;40(4):398-406
pubmed: 24912073
Mol Vis. 2015 Jan 15;21:40-60
pubmed: 25593512
Invest Ophthalmol Vis Sci. 2015 May;56(5):3242-52
pubmed: 25758814
Am J Ophthalmol. 2015 Jul;160(1):85-93.e3
pubmed: 25857680
Eye (Lond). 2015 Aug;29(8):992-1002
pubmed: 26043704
Prog Retin Eye Res. 2016 Mar;51:69-89
pubmed: 26344735
Adv Exp Med Biol. 2016;854:757-63
pubmed: 26427486
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6404-13
pubmed: 26444721
J Biol Chem. 2015 Dec 25;290(52):31189-98
pubmed: 26565031
Immunobiology. 2016 Jun;221(6):733-9
pubmed: 26742632
Transl Vis Sci Technol. 2016 Feb 16;5(1):6
pubmed: 26929886
Acta Ophthalmol. 2016 Aug;94(5):427-33
pubmed: 27009526
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2763-9
pubmed: 27196323
Acta Ophthalmol. 2016 Sep;94(6):556-64
pubmed: 27287874
Mol Vis. 2016 Jul 30;22:898-916
pubmed: 27555739
Sci Rep. 2016 Aug 30;6:31531
pubmed: 27572114
Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1691-9
pubmed: 2759786
Sci Rep. 2016 Sep 08;6:32548
pubmed: 27605007
Retina. 2016 Dec;36 Suppl 1:S26-S39
pubmed: 28005661
PLoS One. 2018 May 10;13(5):e0196481
pubmed: 29746512
Surv Ophthalmol. 1987 Mar-Apr;31(5):291-306
pubmed: 3299827
Invest Ophthalmol Vis Sci. 1978 Jul;17(7):601-7
pubmed: 669891
Ophthalmology. 1997 Jan;104(1):7-21
pubmed: 9022098
Invest Ophthalmol Vis Sci. 1999 Feb;40(2):443-9
pubmed: 9950604